# A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)

> **NCT07210463** · PHASE3 · RECRUITING · sponsor: **Merz Aesthetics GmbH** · enrollment: 300 (estimated)

## Conditions studied

- Neuromuscular Agents
- Peripheral Nervous System Agents
- Physiological Effects of Drugs
- Acetylcholine Release Inhibitors
- Membrane Transport Modulators
- Molecular Mechanisms of Pharmacological Action
- Cholinergic Agents
- Neurotransmitter Agents
- incobotulinumtoxinA
- Botulinum Toxins, Type A

## Interventions

- **DRUG:** NT 201
- **DRUG:** NT 201 Placebo

## Key facts

- **NCT ID:** NCT07210463
- **Lead sponsor:** Merz Aesthetics GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2027-01
- **Final completion:** 2027-11
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07210463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07210463, "A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07210463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*